BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025
Three poster presentations at the San Antonio Breast Cancer Symposium (SABCS), now available and to be presented on December 10,...
Day: December 2, 2025
Nkarta to Participate in Evercore Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered...
Pluristyx Launches Organoid COMMONS, Uniting Industry Leaders to Revolutionize Drug Discovery
Pluristyx to lead a new public-private consortium with 9 other industry leaders to establish global standards for non-animal drug testing...
Ventyx Provides Clinical and Corporate Updates
Strengthening our Advisory Board with addition of Mark McKenna as Strategic Advisor and Peter Libby, MD as a Clinical AdvisorExpanding...
Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss
– Study, Which Enrolled 27 Patients, Met Primary Endpoint with a Significant Reduction in Hearing Loss in 3-18 Year Old...
Aleen Inc. Advances Development of Smart Analytics Feature
Toronto, Ontario--(Newsfile Corp. - December 2, 2025) - Aleen Inc. (CSE: ALEN.U), a digital wellness company, continues its structured path...
Functional Brands Inc. Announces P2i(TM) by Kirkman(R) as the World’s First Prenatal Supplement to Fully Align with FIGO’s Transparency Standards – and the First to Comply with California’s New SB 646 QR-Code Disclosure Law
Lake Oswego, Oregon--(Newsfile Corp. - December 2, 2025) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and...
Delota Reports Financial Results for the Three and Six Months Ended September 30, 2025
Highlights: Total revenue of $8.7 million for the Three Months Ended 2026Total System-Wide Revenue of $10.4 million for the Three...
Cheelcare to Represent Canadian Health Innovation at Health Tech Forward 2025 in Barcelona
Toronto, Ontario--(Newsfile Corp. - December 2, 2025) - Cheelcare (TSXV: CHER), a Canadian innovator in advanced mobility solutions, was selected...
Heard Launches Private Practice Launch Grant Program for Mental Health Professionals
Financial Services Company Awards $42,000+ in Support to Help Three Therapists Launch Private Practices SEATTLE--(BUSINESS WIRE)--Heard, a leading financial services...
Neusoft Medical Systems Unveils World’s First 8cm Wide-Coverage Photon-Counting CT and Other Premium Innovations at RSNA 2025
CHICAGO, Dec. 2, 2025 /PRNewswire/ -- Neusoft Medical Systems Co., Ltd. ("Neusoft Medical"), a global leader in medical imaging, is showcasing...
Tata Elxsi, University of Illinois Urbana-Champaign, and OSF HealthCare Partner to Transform Rural Healthcare Access in the United States
Collaboration Leverages Digital Kiosks and AI-Driven Platforms to Bridge Healthcare GapsBENGALURU, India and CHICAGO, Dec. 2, 2025 /PRNewswire/ -- Tata...
ZAGENO Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition for Excellence in Life Sciences E-commerce Leadership
ZAGENO earns global recognition for driving innovation, operational efficiency, and transformative customer value across the life sciences e-commerce ecosystem.SAN ANTONIO,...
Cyber Monday 2025: Honey Play Box Joins the Holiday Tech Deals
CHINO, Calif., Dec. 1, 2025 /PRNewswire/ -- Honey Play Box is ending the Black Friday weekend with a bang! With...
GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer’s and Other Neurodegenerative Diseases
Phase 1 results show that SUL-238 is safe, well-tolerated, and demonstrates favorable pharmacokinetics with high CSF penetration in healthy elderly...